Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	340.2	233	251.1	262.9	340.8	187.1
Short-Term Investments	774.6	843.1	780.5	726.4	370.5	613.9
Cash & Short-Term Investments	1,115	1,076	1,032	989.3	711.3	801
Cash Growth	-9.22%	4.31%	4.28%	39.08%	-11.20%	19.46%
Receivables	728	479.1	439.3	350	185.5	157.1
Inventory	69.3	57.4	38.3	35.1	30.5	28
Other Current Assets	68.2	112.1	97.8	79.1	45.5	30.1
Total Current Assets	2,158	1,725	1,607	1,454	972.8	1,016
Property, Plant & Equipment	566.2	592	347.3	145.6	155.8	127.4
Long-Term Investments	1,117	864.3	849.4	401.5	624.4	265.3
Goodwill	-	5.7	5.8	5.4	-	-
Other Intangible Assets	35.7	36.5	35.5	37.2	-	-
Long-Term Deferred Tax Assets	368.5	485.7	362.6	305.9	315.1	319.4
Other Long-Term Assets	20.3	9.8	43.8	19.6	4.4	6.4
Total Assets	4,266	3,719	3,251	2,369	2,073	1,735
Accounts Payable	119.9	110	133.3	67.3	51.5	39.4
Accrued Expenses	464.4	351.6	315.5	271.3	111.6	94.7
Current Portion of Long-Term Debt	-	-	170.1	169.4	-	-
Current Portion of Leases	51.3	40.6	-	-	-	-
Current Income Taxes Payable	-	-	-	9	-	-
Current Unearned Revenue	-	-	-	-	62.7	34.6
Other Current Liabilities	2.4	5.5	35.9	20.7	20	17.8
Total Current Liabilities	638	507.7	654.8	537.7	245.8	186.5
Long-Term Debt	-	-	-	-	335.1	317.9
Long-Term Leases	428.4	455.1	258.3	93.5	105.3	94.4
Other Long-Term Liabilities	195.7	166.2	106.3	29.7	12.3	9.7
Total Liabilities	1,262	1,129	1,019	660.9	698.5	608.5
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Additional Paid-In Capital	2,696	2,555	2,382	2,122	2,011	1,850
Retained Earnings	294	29.2	-157.1	-406.8	-635.8	-725.4
Comprehensive Income & Other	13.2	5.8	7	-7.9	-1.7	1.8
Shareholders' Equity	3,004	2,590	2,232	1,708	1,374	1,126
Total Liabilities & Equity	4,266	3,719	3,251	2,369	2,073	1,735
Total Debt	479.7	495.7	428.4	262.9	440.4	412.3
Net Cash (Debt)	635.1	580.4	603.2	726.4	270.9	388.7
Net Cash Growth	-32.56%	-3.78%	-16.96%	168.14%	-30.31%	122.11%
Net Cash Per Share	6.21	5.60	5.97	7.34	2.77	3.97
Filing Date Shares Outstanding	99.71	99.7	99.51	96.59	95.24	93.94
Total Common Shares Outstanding	99.7	99.4	98.7	96.5	94.9	93.5
Working Capital	1,520	1,217	952.2	915.8	727	829.7
Book Value Per Share	30.13	26.05	22.61	17.70	14.48	12.04
Tangible Book Value	2,968	2,548	2,191	1,665	1,374	1,126
Tangible Book Value Per Share	29.77	25.63	22.20	17.26	14.48	12.04
Machinery	-	153.2	115.7	87	75.6	56.8
Leasehold Improvements	-	35.9	38.1	37.9	34.9	29.5

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q